[Skip to content]

EPDA - European Parkinsons Disease Association

EPDA - European Parkinsons Disease Association

EPDA - Awareness

EPDA - Coping Strategies

EPDA - Medical Information

EPDA - Patient Guide

EPDA - Site Map

EPDA - Rewrite Tomorrow

Contact Us |
Login |
Accessibility |
Low graphics |
Text Size: A A A

EUROPEAN PARKINSON'S DISEASE ASSOCIATION

.

Archived news

2010

Search

Search for

GlaxoSmithKline and Impax Pharmaceuticals enter global agreement to develop and commercialise late stage compound for Parkinson'GlaxoSmithKline (GSK) and Impax Pharmaceuticals, announces agreement for the development and commercialisation of IPX066, Impax's novel extended release carbidopa-levodopa product, outside the United States and Taiwan. IPX066, an investigational product under development for the treatment of Parkinson's Disease (PD), is currently in Phase III clinical trials. 16 December 2010
Report of the EPF High-Level Roundtable on Cross-Border Healthcare14 December 2010
EPF November update on EU health developments from a patients perspective now available30 November 2010
Sensidose: Successful clinical studies of the treatment of Parkinson's disease with microtabletsSensidose AB in Uppsala, Sweden, has developed a system for individual dosing of drugs in tablet form. The system includes an electronic dosing device for drugs given in the form of microtablets, and functions for the registration of symptoms. 04 November 2010
EAASM October 2010 newsletter02 November 2010
EPF paves the way for the EU Hungarian Presidency through a unique regional seminar strengthening young patient advocacyThe European Patients' Forum (EPF), together with the Hungarian Osteoporosis Patient Association (HOPA) held their annual regional advocacy seminar in Budapest October 25-27. 27 October 2010
NEF Press Release: Electronic Patient Records – NHS at risk of undermining public trustThe digitisation of patient records needs much wider consultation if the NHS is to retain public confidence in patient confidentiality, says a new survey published today (11 October) by nef (the new economics foundation) and the Centre for Science Education at Sheffield Hallam University. 11 October 2010
European Medicines Agency Management Board adopt new policies on handling of conflicts of interests and on access to documentsThe board endorsed the new EMA policy on handling of conflicts of interests, introducing a more efficient, robust and transparent process ensuring that scientific committee members and experts participating in the Agency's activities have no interests in the pharmaceutical industry which could affect their impartiality. 08 October 2010
EPDA steps up awareness campaign with launch of non-motor symptoms materialsThe EPDA has launched the second part of its successful Life with Parkinson's awareness campaign at the 2nd World Parkinson Congress (WPC) in Glasgow, Scotland. 04 October 2010
EPF September update on EU health developments from a patients perspective now available30 September 2010

Page: [1] [2] [3] [4] [5]

[ Next » ]